Schalch D, Reismann D, Emler C, Humbel R, Li C H, Peters M, Lau E
Endocrinology. 1984 Dec;115(6):2490-2. doi: 10.1210/endo-115-6-2490.
Investigation of the biologic activity of Insulin-like Growth Factor I/Somatomedin C (IGF-I/Sm C) has been hampered by the scarcity of purified material. The synthesis of this molecule by the solid phase procedure and an analog of IGF-I/Sm C by recombinant DNA technology offers promise that studies of the biologic activity of IGF-I/Sm C will soon be possible. We have found that natural IGF-I/Sm C and the two synthetic peptides behave similarly in two radioligand systems, providing evidence that these molecules possess the requisite structural integrity for use in such biological studies.
胰岛素样生长因子I/生长调节素C(IGF-I/Sm C)生物活性的研究因纯化材料的匮乏而受阻。通过固相法合成该分子以及利用重组DNA技术合成IGF-I/Sm C的类似物,为不久后开展IGF-I/Sm C生物活性研究带来了希望。我们发现,天然IGF-I/Sm C和这两种合成肽在两种放射性配体系统中的表现相似,这证明这些分子具备用于此类生物学研究所需的结构完整性。